359
Participants
Start Date
July 29, 2021
Primary Completion Date
August 5, 2024
Study Completion Date
August 5, 2024
FF/VI
FF/VI will be administered.
FF/UMEC/VI
FF/UMEC/VI will be administered.
ELLIPTA
FF/UMEC/VI and FF/VI will be administered via ELLIPTA inhaler.
GSK Investigational Site, Taiyuan
GSK Investigational Site, Qinhuangdao
GSK Investigational Site, Beijing
GSK Investigational Site, Shenyang
GSK Investigational Site, Shenyang
GSK Investigational Site, Changchun
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Shanghai
GSK Investigational Site, Nanjing
GSK Investigational Site, Wuxi
GSK Investigational Site, Xuzhou
GSK Investigational Site, Lianyungang
GSK Investigational Site, Hefei
GSK Investigational Site, Jinan
GSK Investigational Site, Qingdao
GSK Investigational Site, Tianjin
GSK Investigational Site, Hangzhou
GSK Investigational Site, Hangzhou
GSK Investigational Site, Wenzhou
GSK Investigational Site, Nanchang
GSK Investigational Site, Fuzhou
GSK Investigational Site, Xiamen
GSK Investigational Site, Chongqing
GSK Investigational Site, Changsha
GSK Investigational Site, Wuhan
GSK Investigational Site, Wuhan
GSK Investigational Site, Zhengzhou
GSK Investigational Site, Xinxiang
GSK Investigational Site, Qingyuan
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Guangzhou
GSK Investigational Site, Huizhou
GSK Investigational Site, Shenzhen
GSK Investigational Site, Shenzhen
GSK Investigational Site, Shenzhen
GSK Investigational Site, Dongguan
GSK Investigational Site, Zhanjiang
GSK Investigational Site, Zhanjiang
GSK Investigational Site, Zhongshan
GSK Investigational Site, Jiangmen
GSK Investigational Site, Nanning
GSK Investigational Site, Guilin
GSK Investigational Site, Guilin
GSK Investigational Site, Zunyi
GSK Investigational Site, Sanya
GSK Investigational Site, Chengdu
GSK Investigational Site, Kunming
GSK Investigational Site, Xi'an
GSK Investigational Site, Lanzhou
GSK Investigational Site, Yinchuan
GSK Investigational Site, Ürümqi
GSK Investigational Site, Chongqing
GSK Investigational Site, Sanya
GSK Investigational Site, Hohhot
GSK Investigational Site, Hohhot
GSK Investigational Site, Shijiazhuang
Lead Sponsor
GlaxoSmithKline
INDUSTRY